Tag: EVOLVE

EVOLVE Expansion study: vedolizumab and ustekinumab as first-line biologic treatments for Crohn’s disease

Presented By
Prof. Marc Ferrante, KU Leuven, Belgium
Trial
EVOLVE
Conference
DDW 2023
Type
News article

13 June 2023 13:56

Vedolizumab and anti-TNF therapies: a real-world comparison

Presented By
Dr G. Mantzaris , Evangelismos Hospital, Greece
Trial
EVOLVE
Conference
ECCO 2020
Type
Peer-reviewed article

14 April 2020 15:35
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com